Insulet Corp (PODD)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$320.20
Buy
$344.00
$2.73 (+0.85%)
Prices updated at 16 May 2025, 21:20 EDT
| Prices minimum 15 mins delay
Prices in USD
Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
---|---|---|
1,697m | 2,072m | |
1,160m | 1,446m | |
220m | 309m | |
12.96 | 14.91 | |
206m | 418m | |
324m | 424m | |
Sales, General and administrative | 735m | 917m |
Interest expenses | 36m | 43m |
Provision for income taxes | 8m | -118m |
Operating expenses | 940m | 1,137m |
Income before taxes | 215m | 300m |
Net income available to common shareholders | 206m | 418m |
2.96 | 5.97 | |
Net interest income | -8m | -3m |
Advertising and promotion | - | - |
Net investment income, net | - | - |
Realised capital gains (losses), net | - | - |
Total benefits, claims and expenses | - | - |
Earnings per share (diluted) | 2.94 | 5.78 |
Free cash flow per share | -0.21 | 2.8552 |
Book value/share | 8.6901 | 15.9268 |
Debt equity ratio | 1.864883 | 1.069742 |
Balance sheet
Year | 2023 | 2024 |
---|---|---|
Current assets | 1,583m | 1,891m |
Current liabilities | 451m | 528m |
Total capital | 2,099m | 2,508m |
Total debt | 1,416m | 1,392m |
Total equity | 733m | 1,212m |
Total non current liabilities | - | - |
Loans | 1,366m | 1,296m |
Total assets | 2,588m | 3,088m |
Total liabilities | - | - |
Cash and cash equivalents | 704m | 953m |
Common stock | 70m | 70m |
Cash flow
Year | 2023 | 2024 |
---|---|---|
Cash at beginning of period | 690m | 704m |
Cash dividends paid | - | - |
37m | 296m | |
Investments (gains) losses | -119m | -146m |
704m | 953m | |
Net income | - | - |
146m | 430m | |
-109m | -134m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.